Provided by Tiger Trade Technology Pte. Ltd.

Prime Medicine, Inc.

3.35
-0.1200-3.46%
Post-market: 3.370.0200+0.60%19:47 EDT
Volume:2.39M
Turnover:8.02M
Market Cap:604.71M
PE:-3.09
High:3.42
Open:3.37
Low:3.31
Close:3.47
52wk High:6.94
52wk Low:2.67
Shares:180.51M
Float Shares:116.00M
Volume Ratio:0.84
T/O Rate:2.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0853
EPS(LYR):-1.3521
ROE:-373.29%
ROA:-46.52%
PB:15.19
PE(LYR):-2.48

Loading ...

Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for Pm577a in H1069q-Mutated Wilson Disease

THOMSON REUTERS
·
Jun 18

Prime Medicine, - Phase 1/2 Trial Initiation Expected in H2 2026; Initial Data Expected in 2027

THOMSON REUTERS
·
Jun 18

Is Prime Medicine (NASDAQ:PRME) In A Good Position To Invest In Growth?

Simply Wall St.
·
Jun 18

Prime Medicine shareholders elect Kelly, Schenkein as Class I directors at annual meeting

Reuters
·
Jun 09

Prime Medicine posts corporate deck outlining prime editing pipeline focus on Wilson disease, AATD

Reuters
·
Jun 02

Analysts Conflicted on These Healthcare Names: Kyverna Therapeutics, Inc. (KYTX), Immunome (IMNM) and Prime Medicine, Inc. (PRME)

TIPRANKS
·
May 13

Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), VistaGen Therapeutics (VTGN) and Prime Medicine, Inc. (PRME)

TIPRANKS
·
May 09

Wedbush Keeps Their Buy Rating on Prime Medicine, Inc. (PRME)

TIPRANKS
·
May 09

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Whitehawk Therapeutics (WHWK), Prime Medicine, Inc. (PRME) and Argenx Se (ARGX)

TIPRANKS
·
May 08

Prime Medicine Q1 EPS $(0.28) Misses $(0.25) Estimate, Sales $856.000K Miss $1.065M Estimate

Benzinga Earnings
·
May 07

Prime Medicine Q1 net loss narrows as R&D expenses fall

Reuters
·
May 07

BRIEF-Prime Medicine, Inc. Q1 EPS USD -0.28

Reuters
·
May 07

Prime Medicine, Inc. Q1 Income From Operations USD -50.654 Million

THOMSON REUTERS
·
May 07

Press Release: Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates

Dow Jones
·
May 07

Prime Medicine announces annual stockholders meeting via webcast

Reuters
·
Apr 23

Prime Medicine CFO Svetlana Ni Makhni files initial beneficial ownership statement

Reuters
·
Apr 18

Prime Medicine Names Svetlana Makhni CFO

MT Newswires Live
·
Apr 16

Press Release: Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer

Dow Jones
·
Apr 16

Prime Medicine, Inc. (PRME) Receives a Buy from JonesTrading

TIPRANKS
·
Apr 07